Microtubule Regulation

微管调节

基本信息

  • 批准号:
    7931456
  • 负责人:
  • 金额:
    $ 16.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The essential function of mitosis is the delivery of a complete set of chromosomes to each daughter cell. This requires attachment of spindle microtubules to kinetochores, specialized structures formed at centromeres. Kinetochores are more than just structural elements that mediate faithful chromosome inheritance. The unattached kinetochore is also the signal generator for the mitotic checkpoint (also known as the spindle assembly checkpoint), the major cell cycle control mechanism in mitosis. Each unattached kinetochore generates a "wait anaphase" inhibitor that blocks destruction of cyclin B and securin, thereby blocking disjoining of duplicated sister chromosomes and advance into anaphase. We have previously identified a microtubule-dependent motor, CENPE, to be multifunctional these mitotic events. It directly tethers spindle microtubules to kinetochores and it functions as the cyclin-like activator of the essential mitotic checkpoint kinase BubR1. Microtubule capture by CENP-E in turn inactivates BubR1 kinase activity, thereby silencing mitotic checkpoint signaling and permitting anaphase onset. We now propose to determine the properties of CENP-E in microtubule capture at kinetochores (with electron microscopy), the motor properties of CENP-E (including processivity and residence time when microtubule bound), and how CENP-E acts to affect coupling to dynamic microtubules. The functional role of an unusual CENPE modification, farnesylation, will be determined. A major effort will use all purified components to reconstruct mitotic checkpoint signaling in vitro and to identify the "wait anaphase" inhibitor(s) produced by unattached kinetochores. Moreover, recognizing that most human solid tumors are aneuploid, that is, have other than the correct number of 46 chromosomes, we will exploit our discovery that reduced levels of CENP-E generate accelerated rates of such aneuploidy to enable a test of how whole chromosomal aneuploidy affects tumorigenesis initiated by loss of each of the major tumor suppressor genes. This will provide a test of the hypothesis posed more than 100 years ago by the great cytologist Boveri that aneuploidy drives tumorigenesis. Finally, recognizing that successful cancer therapeutics such as taxol yield chronic activation of the mitotic checkpoint, we will examine the mechanisms underlying cell death or adaptation after chrom0ic mitotic checkpoint arrest. PUBLIC HEALTH RELEVANCE: Unattached kinetochores control the cell cycle clock during cell division by generating a "wait" signal, the mitotic checkpoint, which delays cell cycle advance until all chromosomes have successfully attached to spindle microtubules. How this signaling works will be examined by determining how a kinetochore motor protein affects chromosome attachment to spindle microtubules and acts to activate and silence an essential checkpoint kinase. The overall signaling pathway will be determined by reconstructing it from individual components. Finally, since some successful anti-tumor drugs in humans chronically activate the mitotic checkpoint, the mechanisms tha determine cell fate, cell death or adaptation, when so arrested will be determined.
描述(申请人提供):有丝分裂的基本功能是将一套完整的染色体传递给每个子细胞。这需要纺锤体微管附着在着丝粒上,着丝粒上形成的特殊结构。着丝点不仅仅是调节忠实染色体遗传的结构元素。独立的动粒也是有丝分裂检查点(也称为纺锤体组装检查点)的信号发生器,有丝分裂中主要的细胞周期控制机制。每个独立的动粒产生一个“等待后期”抑制物,阻止细胞周期蛋白B和Securin的破坏,从而阻止复制的姐妹染色体的分离并进入后期。我们以前已经发现微管依赖的运动,CENPE,是这些有丝分裂事件的多功能分子。它直接将纺锤体微管连接到动点,并作为必要的有丝分裂检查点激酶BubR1的周期素样激活剂发挥作用。由CENP-E捕获的微管反过来使BubR1激酶活性失活,从而沉默有丝分裂检查点信号并允许后期开始。我们现在建议确定CENP-E在运动中心捕获微管中的性质(用电子显微镜),CENP-E的运动性质(包括微管结合时的加工性和停留时间),以及CENP-E如何影响与动态微管的耦合。一种不寻常的CENPE修饰,法尼化,其功能作用将被确定。一项主要的工作将使用所有纯化的成分在体外重建有丝分裂检查点信号,并鉴定由分离的动点产生的等待后期抑制物(S)。此外,认识到大多数人类实体肿瘤是非整倍体,即具有不同于正确数目的46条染色体,我们将利用我们的发现,即降低CENP-E水平会加速这种非整倍体的发生,从而能够测试整个染色体非整倍体如何影响由每个主要肿瘤抑制基因丢失引发的肿瘤发生。这将对100多年前伟大的细胞学家博弗里提出的非整倍体驱动肿瘤发生的假说进行检验。最后,认识到成功的癌症治疗方法,如紫杉醇,可导致有丝分裂检查点的慢性激活,我们将研究细胞死亡或染色体有丝分裂检查点停止后适应的机制。与公共健康相关:在细胞分裂过程中,独立的动点通过产生“等待”信号来控制细胞周期时钟,即有丝分裂检查点,该信号会延迟细胞周期的推进,直到所有的染色体都成功地附着在纺锤体微管上。通过确定动粒运动蛋白如何影响染色体与纺锤体微管的连接,以及如何激活和沉默必要的检查点激酶,将研究这种信号是如何发挥作用的。整个信号通路将通过从单个组件重建来确定。最后,由于一些成功的人类抗肿瘤药物长期激活有丝分裂检查点,决定细胞命运、细胞死亡或适应的机制将被确定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Don W Cleveland其他文献

Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease
胶质细胞作为非细胞自主性神经退行性疾病的内在成分
  • DOI:
    10.1038/nn1988
  • 发表时间:
    2007-10-26
  • 期刊:
  • 影响因子:
    20.000
  • 作者:
    Christian S Lobsiger;Don W Cleveland
  • 通讯作者:
    Don W Cleveland
VEGF: multitasking in ALS
血管内皮生长因子:在肌萎缩侧索硬化症中的多任务处理
  • DOI:
    10.1038/nn0105-5
  • 发表时间:
    2005-01-01
  • 期刊:
  • 影响因子:
    20.000
  • 作者:
    Christine Vande Velde;Don W Cleveland
  • 通讯作者:
    Don W Cleveland

Don W Cleveland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Don W Cleveland', 18)}}的其他基金

In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies
TDP-43 蛋白病中 stathmin-2 缺失的体内建模和治疗开发
  • 批准号:
    10317404
  • 财政年份:
    2021
  • 资助金额:
    $ 16.27万
  • 项目类别:
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD
确定 Stathmin-2 的功能和作为 ALS/FTD 治疗靶点的潜力
  • 批准号:
    10835733
  • 财政年份:
    2020
  • 资助金额:
    $ 16.27万
  • 项目类别:
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD
确定 Stathmin-2 的功能和作为 ALS/FTD 治疗靶点的潜力
  • 批准号:
    10370327
  • 财政年份:
    2020
  • 资助金额:
    $ 16.27万
  • 项目类别:
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
染色体分离、非整倍性和肿瘤发生的机制
  • 批准号:
    10674798
  • 财政年份:
    2017
  • 资助金额:
    $ 16.27万
  • 项目类别:
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
染色体分离、非整倍性和肿瘤发生的机制
  • 批准号:
    9883009
  • 财政年份:
    2017
  • 资助金额:
    $ 16.27万
  • 项目类别:
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
染色体分离、非整倍性和肿瘤发生的机制
  • 批准号:
    10406521
  • 财政年份:
    2017
  • 资助金额:
    $ 16.27万
  • 项目类别:
Junior Faculty and Postdoctoral Fellows Career Development Workshop
初级教师和博士后研究员职业发展研讨会
  • 批准号:
    8720394
  • 财政年份:
    2014
  • 资助金额:
    $ 16.27万
  • 项目类别:
MUTANT SOD1 ASSOCIATION WITH MITOCHONDRIA
突变体 SOD1 与线粒体的关联
  • 批准号:
    8365861
  • 财政年份:
    2011
  • 资助金额:
    $ 16.27万
  • 项目类别:
PHOSPHORYLATION OF MAD1 BY TTK
TTK 磷酸化 MAD1
  • 批准号:
    8171354
  • 财政年份:
    2010
  • 资助金额:
    $ 16.27万
  • 项目类别:
CHARACTERIZATION OF THE PLK4 KINASE
PLK4 激酶的表征
  • 批准号:
    8171423
  • 财政年份:
    2010
  • 资助金额:
    $ 16.27万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 16.27万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了